Progestin [EPC]

Progestin [EPC] was reported 291345 times

Drugs of the Progestin [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 VAGINAL CONTRACEPTIVE DEVICE EXPELLED 140 1.0000
1 INTRA-UTERINE CONTRACEPTIVE DEVICE EXPELLED 5578 0.9922
2 ECTOPIC PREGNANCY WITH INTRAUTERINE DEVICE 292 0.9669
3 IUCD COMPLICATION 2445 0.9404
4 MEDICAL DEVICE MONITORING ERROR 259 0.9283
5 IMPLANT SITE INJURY 136 0.9252
6 IUD MIGRATION 794 0.9190
7 IMPLANT SITE HYPOAESTHESIA 191 0.9052
8 CONTRAINDICATED DEVICE USED 287 0.8858
9 UTERINE PERFORATION 7467 0.8812
10 GENITAL HAEMORRHAGE 11268 0.8752
11 PREGNANCY AFTER POST COITAL CONTRACEPTION 1978 0.8748
12 UTERINE CERVIX STENOSIS 458 0.8593
13 IMPLANT SITE URTICARIA 83 0.8469
14 IMPLANT SITE BRUISING 631 0.8425
15 DEVICE IMPLANTATION ERROR 71 0.8353
16 IMPLANT SITE PARAESTHESIA 125 0.8333
17 POST PROCEDURAL DISCOMFORT 1730 0.8258
18 IMPLANT SITE PRURITUS 743 0.8256
19 MEDICAL DEVICE DISCOMFORT 2515 0.8224
20 ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE 1393 0.8170
21 INTRA-UTERINE CONTRACEPTIVE DEVICE REMOVAL 215 0.8022
22 DIFFICULTY REMOVING DRUG IMPLANT 144 0.8000
23 IMPLANT SITE IRRITATION 298 0.7863
24 MIGRATION OF IMPLANTED DRUG 409 0.7761
25 IMPLANT SITE DISCOLOURATION 119 0.7727
26 MEDICAL DEVICE SITE DISCOMFORT 619 0.7709
27 DEVICE EXPULSION 49529 0.7630
28 IMPLANT SITE FIBROSIS 383 0.7629
29 PREGNANCY WITH IMPLANT CONTRACEPTIVE 3529 0.7520
30 IMPLANT SITE RASH 267 0.7458
31 PREGNANCY WITH CONTRACEPTIVE DEVICE 6550 0.7305
32 IMPLANT SITE PAIN 3258 0.7284
33 UTERINE RUPTURE 1020 0.7208
34 IMPLANT SITE ERYTHEMA 747 0.7203
35 IMPLANT SITE VESICLES 105 0.7143
36 MEDICAL DEVICE PAIN 1516 0.7074
37 IMPLANT SITE SCAR 523 0.6992
38 DEVICE EMBOLISATION 203 0.6881
39 IMPLANT SITE INDURATION 78 0.6842
40 LOOP ELECTROSURGICAL EXCISION PROCEDURE 96 0.6761
41 IMPLANT SITE CELLULITIS 158 0.6752
42 MENSTRUATION IRREGULAR 17874 0.6666
43 IMPLANT SITE HYPERSENSITIVITY 73 0.6577
44 DEVICE KINK 2364 0.6482
45 MENSTRUATION DELAYED 7007 0.6459
46 COITAL BLEEDING 969 0.6216
47 IMPLANT SITE MASS 121 0.6142
48 MENSTRUATION NORMAL 200 0.6024
49 RUPTURED ECTOPIC PREGNANCY 464 0.5987
50 HYPOMENORRHOEA 1633 0.5949
51 IMPLANT SITE WARMTH 90 0.5806
52 IMPLANT SITE HAEMORRHAGE 254 0.5721
53 IMPLANT SITE SWELLING 582 0.5711
54 FALLOPIAN TUBE PERFORATION 51 0.5667
55 GENERAL ANAESTHESIA 247 0.5477
56 UTERINE SPASM 1001 0.5467
57 DEVICE DISLOCATION 23664 0.5437
58 MENOMETRORRHAGIA 1034 0.5416
59 COMPLICATION OF DEVICE INSERTION 10567 0.5306
60 ENCAPSULATION REACTION 54 0.5243
61 UTERINE CERVICAL PAIN 102 0.5231
62 DEVICE MISUSE 687 0.5197
63 IMPLANT SITE ABSCESS 97 0.5026
64 INTERNAL INJURY 325 0.4985
65 VAGINAL MYCOSIS 116 0.4979
66 COMPLICATION ASSOCIATED WITH DEVICE 7061 0.4858
67 ABORTION OF ECTOPIC PREGNANCY 58 0.4833
68 UTERINE SCAR 111 0.4826
69 DYSPAREUNIA 2175 0.4732
70 UTERINE INJURY 78 0.4615
71 DYSMENORRHOEA 6085 0.4585
72 UNINTENDED PREGNANCY 4772 0.4562
73 DEVICE PLACEMENT ISSUE 1633 0.4555
74 DEVICE COMPONENT ISSUE 66 0.4490
75 GENITAL DISCHARGE 107 0.4477
76 VAGINITIS BACTERIAL 282 0.4455
77 PELVIC INFLAMMATORY DISEASE 662 0.4434
78 VAGINAL HAEMORRHAGE 19234 0.4427
79 IMPLANT SITE INFLAMMATION 128 0.4369
80 AMENORRHOEA 7663 0.4366
81 VENA CAVA FILTER INSERTION 137 0.4349
82 UTERINE ADHESIONS 56 0.4341
83 OFF LABEL USE OF DEVICE 576 0.4257
84 UTERINE PAIN 433 0.4216
85 ACTINOMYCES TEST POSITIVE 54 0.4186
86 ADNEXA UTERI PAIN 514 0.4016
87 IMPLANT SITE REACTION 180 0.3965
88 PELVIC PAIN 7208 0.3963
89 EMBEDDED DEVICE 3926 0.3960
90 COMPLICATION OF DEVICE REMOVAL 7071 0.3907
91 VAGINAL DISCHARGE 3947 0.3897
92 INFERTILITY FEMALE 603 0.3875
93 MENORRHAGIA 7587 0.3860
94 IMPLANT SITE DISCHARGE 144 0.3840
95 ABDOMINAL PAIN LOWER 9639 0.3808
96 PENILE PAIN 1153 0.3784
97 PROCEDURAL DIZZINESS 122 0.3777
98 RETAINED PRODUCTS OF CONCEPTION 77 0.3756
99 PELVIC ADHESIONS 89 0.3724
100 DEVICE DEPLOYMENT ISSUE 4720 0.3691
101 BREAST TENDERNESS 2772 0.3677
102 DEVICE INTOLERANCE 87 0.3655
103 POST ABORTION HAEMORRHAGE 52 0.3636
104 HYDROMETRA 66 0.3587
105 POLYMENORRHOEA 1236 0.3561
106 OVULATION PAIN 73 0.3476
107 SUPPRESSED LACTATION 261 0.3475
108 VAGINAL ODOUR 424 0.3368
109 HAEMORRHAGE IN PREGNANCY 467 0.3257
110 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 327 0.3247
111 HEAVY MENSTRUAL BLEEDING 2894 0.3213
112 IDIOPATHIC INTRACRANIAL HYPERTENSION 722 0.3207
113 ABNORMAL WITHDRAWAL BLEEDING 293 0.3185
114 ANTEPARTUM HAEMORRHAGE 130 0.3133
115 PROCEDURAL PAIN 8675 0.3124
116 PREMENSTRUAL SYNDROME 428 0.3113
117 ABNORMAL MENSTRUAL CLOTS 54 0.3086
118 IMPLANT SITE INFECTION 705 0.3028
119 MEDICAL DEVICE COMPLICATION 2222 0.3002
120 TUBO-OVARIAN ABSCESS 73 0.2992
121 SALPINGITIS 94 0.2947
122 METRORRHAGIA 4994 0.2926
123 WITHDRAWAL BLEED 206 0.2826
124 CHLAMYDIAL INFECTION 208 0.2751
125 PREMENSTRUAL DYSPHORIC DISORDER 55 0.2709
126 UTERINE INFLAMMATION 58 0.2673
127 MENSTRUAL CLOTS 63 0.2625
128 MENSTRUAL DISORDER 2164 0.2610
129 UTERINE INFECTION 135 0.2552
130 EXPIRED DEVICE USED 837 0.2522
131 PREGNANCY TEST POSITIVE 99 0.2519
132 CERVICITIS 112 0.2511
133 UTERINE HAEMORRHAGE 1071 0.2511
134 GENITAL PAIN 371 0.2508
135 PELVIC DISCOMFORT 233 0.2463
136 INCORRECT PRODUCT ADMINISTRATION DURATION 5302 0.2445
137 DEVICE BREAKAGE 9756 0.2401
138 OVARIAN CYST 2382 0.2381
139 SMEAR CERVIX ABNORMAL 338 0.2379
140 DEVICE ALLERGY 59 0.2360
141 IMPLANT SITE HAEMATOMA 57 0.2336
142 SALPINGECTOMY 132 0.2300
143 CERVICAL DYSPLASIA 501 0.2293
144 PELVIC INFECTION 106 0.2284
145 OLIGOMENORRHOEA 490 0.2245
146 PERITONEAL ADHESIONS 57 0.2244
147 POST PROCEDURAL HAEMORRHAGE 2560 0.2197
148 GONORRHOEA 59 0.2185
149 ECTOPIC PREGNANCY 655 0.2128
150 OVARIAN CYST RUPTURED 272 0.2118
151 HAEMORRHAGIC OVARIAN CYST 120 0.2087
152 HEPATIC ADENOMA 107 0.2070
153 PATIENT-DEVICE INCOMPATIBILITY 141 0.2064
154 BREAST PAIN 2189 0.2051
155 ENDOMETRITIS 136 0.2045
156 PROGESTERONE DECREASED 63 0.2026
157 BACTERIAL VAGINOSIS 316 0.2019
158 CERVIX DISORDER 145 0.2014
159 BENIGN INTRACRANIAL HYPERTENSION 251 0.1998
160 THROMBECTOMY 64 0.1981
161 PENIS INJURY 71 0.1972
162 CERVICAL POLYP 73 0.1926
163 PREGNANCY ON CONTRACEPTIVE 280 0.1916
164 PROCEDURAL HAEMORRHAGE 741 0.1893
165 INTERMENSTRUAL BLEEDING 1041 0.1861
166 CHLOASMA 84 0.1806
167 HIRSUTISM 239 0.1797
168 HYPERCOAGULATION 336 0.1763
169 FEMALE STERILISATION 90 0.1751
170 VOMITING IN PREGNANCY 63 0.1736
171 LOSS OF LIBIDO 1555 0.1727
172 ADENOMYOSIS 101 0.1709
173 UTERINE ENLARGEMENT 134 0.1688
174 PROCEDURAL VOMITING 109 0.1677
175 PROCEDURAL NAUSEA 133 0.1652
176 PREGNANCY TEST FALSE POSITIVE 76 0.1631
177 BREAST DISCOMFORT 168 0.1628
178 HUMAN PAPILLOMA VIRUS TEST POSITIVE 65 0.1597
179 HYPERTRICHOSIS 296 0.1596
180 DEVICE USE ISSUE 2778 0.1586
181 MATERNAL EXPOSURE BEFORE PREGNANCY 1061 0.1552
182 PRODUCT SHAPE ISSUE 145 0.1534
183 PULMONARY INFARCTION 356 0.1504
184 NIPPLE PAIN 303 0.1487
185 DYSFUNCTIONAL UTERINE BLEEDING 178 0.1466
186 MEDICAL DEVICE SITE PAIN 82 0.1456
187 INTRACRANIAL VENOUS SINUS THROMBOSIS 156 0.1455
188 BREAST DISCHARGE 250 0.1425
189 SEXUALLY TRANSMITTED DISEASE 62 0.1425
190 BLIGHTED OVUM 56 0.1425
191 TRANSVERSE SINUS THROMBOSIS 75 0.1423
192 HIGH RISK PREGNANCY 57 0.1407
193 ENDOMETRIAL DISORDER 58 0.1404
194 POLYCYSTIC OVARIES 217 0.1398
195 UTERINE DILATION AND CURETTAGE 125 0.1383
196 DEVICE DIFFICULT TO USE 8876 0.1340
197 UTERINE LEIOMYOMA 972 0.1328
198 ENDOMETRIAL THICKENING 73 0.1311
199 VULVOVAGINAL DISCOMFORT 577 0.1304
200 UTERINE CYST 74 0.1301
201 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 75 0.1293
202 INFERTILITY 193 0.1282
203 PROCEDURAL ANXIETY 86 0.1267
204 BREAST SWELLING 338 0.1256
205 HORMONE LEVEL ABNORMAL 605 0.1239
206 FIBROADENOMA OF BREAST 55 0.1222
207 ABNORMAL UTERINE BLEEDING 313 0.1219
208 PELVIC FLUID COLLECTION 85 0.1206
209 POST THROMBOTIC SYNDROME 53 0.1178
210 VULVOVAGINAL PAIN 561 0.1163
211 FOCAL NODULAR HYPERPLASIA 60 0.1154
212 LACTATION DISORDER 56 0.1150
213 DIFFUSE ALOPECIA 211 0.1136
214 VAGINAL INFECTION 526 0.1117
215 ENDOMETRIAL HYPERPLASIA 90 0.1111
216 BREAST FEEDING 86 0.1101
217 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1250 0.1079
218 VULVOVAGINAL DRYNESS 344 0.1063
219 KELOID SCAR 54 0.1047
220 NIPPLE DISORDER 65 0.1045
221 SUPERIOR SAGITTAL SINUS THROMBOSIS 82 0.1026
222 COMPLICATION OF PREGNANCY 77 0.1012
223 UTERINE POLYP 179 0.0997
224 ENDOMETRIOSIS 475 0.0995
225 ABORTION MISSED 126 0.0992
226 PAPILLOMA VIRAL INFECTION 160 0.0969
227 BREAST CYST 168 0.0948
228 GENITAL DISCOMFORT 52 0.0939
229 HAEMOPERITONEUM 75 0.0936
230 MOOD SWINGS 2977 0.0933
231 VULVOVAGINAL INJURY 53 0.0930
232 DEVICE PHYSICAL PROPERTY ISSUE 706 0.0921
233 VULVOVAGINAL MYCOTIC INFECTION 357 0.0907
234 FIBROCYSTIC BREAST DISEASE 66 0.0894
235 BREAST ENLARGEMENT 289 0.0881
236 PAPILLOEDEMA 381 0.0843
237 ABORTION INDUCED 794 0.0842
238 PREMATURE MENOPAUSE 75 0.0812
239 NO ADVERSE EVENT 14702 0.0811
240 VAGINAL DISORDER 77 0.0802
241 VULVOVAGINAL PRURITUS 402 0.0793
242 PERITONEAL HAEMORRHAGE 109 0.0785
243 PROGESTERONE RECEPTOR ASSAY POSITIVE 73 0.0782
244 VULVOVAGINAL SWELLING 142 0.0777
245 VULVOVAGINAL CANDIDIASIS 105 0.0776
246 INCORRECT DRUG ADMINISTRATION DURATION 2140 0.0760
247 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 58 0.0752
248 CEREBRAL VENOUS THROMBOSIS 136 0.0748
249 DEVICE INEFFECTIVE 79 0.0738
250 INTENTIONAL DEVICE USE ISSUE 62 0.0725
251 SYNCOPE VASOVAGAL 58 0.0702
252 INTRA-ABDOMINAL HAEMORRHAGE 167 0.0701
253 INJURY 4835 0.0687
254 MENOPAUSAL SYMPTOMS 158 0.0678
255 MAMMOPLASTY 53 0.0663
256 ABORTION 192 0.0658
257 ACNE CYSTIC 198 0.0657
258 HAEMANGIOMA OF LIVER 66 0.0655
259 THROMBOPHLEBITIS SUPERFICIAL 187 0.0617
260 MIGRAINE WITH AURA 167 0.0614
261 DEVICE ISSUE 5426 0.0604
262 UTERINE DISORDER 140 0.0600
263 ACTINOMYCOSIS 57 0.0595
264 OOPHORECTOMY 53 0.0594
265 ABORTION SPONTANEOUS 2358 0.0588
266 PRODUCT QUALITY ISSUE 7959 0.0585
267 OVARIAN DISORDER 53 0.0564
268 OESTROGEN RECEPTOR ASSAY POSITIVE 62 0.0547
269 PRODUCT ADHESION ISSUE 1941 0.0543
270 EXPOSURE DURING BREAST FEEDING 177 0.0534
271 EMBOLISM VENOUS 161 0.0530
272 MOOD ALTERED 1393 0.0510
273 DRUG EXPOSURE BEFORE PREGNANCY 50 0.0493
274 PELVIC VENOUS THROMBOSIS 69 0.0481
275 PULMONARY EMBOLISM 4492 0.0472
276 INTRACRANIAL PRESSURE INCREASED 263 0.0471
277 SCAR 807 0.0471
278 WISDOM TEETH REMOVAL 62 0.0470
279 SUBCLAVIAN VEIN THROMBOSIS 53 0.0465
280 MATERNAL EXPOSURE DURING BREAST FEEDING 188 0.0463
281 DEEP VEIN THROMBOSIS 3010 0.0463
282 DEPRESSION SUICIDAL 159 0.0459
283 APPLICATION SITE DISCOMFORT 80 0.0445
284 TONSILLECTOMY 72 0.0430
285 ABDOMINAL PAIN 9987 0.0429
286 BREAST MASS 285 0.0424
287 FEAR OF DISEASE 75 0.0421
288 DEVICE FAILURE 636 0.0417
289 ENDOMETRIAL CANCER 90 0.0409
290 POSTMENOPAUSAL HAEMORRHAGE 105 0.0402
291 BLOOD LOSS ANAEMIA 89 0.0393
292 AFFECTIVE DISORDER 307 0.0390
293 ACNE 2913 0.0384
294 MIGRAINE 3648 0.0382
295 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2712 0.0381
296 POSTPARTUM HAEMORRHAGE 50 0.0371
297 PREGNANCY ON ORAL CONTRACEPTIVE 96 0.0366
298 MEDICAL DEVICE REMOVAL 62 0.0358
299 CYST 432 0.0348
300 PRODUCT PRESCRIBING ISSUE 758 0.0348
301 THROMBOPHLEBITIS 120 0.0342
302 VULVOVAGINAL BURNING SENSATION 208 0.0340
303 GENERALISED ANXIETY DISORDER 49 0.0333
304 PREGNANCY 663 0.0331
305 INVASIVE DUCTAL BREAST CARCINOMA 90 0.0331
306 ABDOMINAL DISTENSION 3442 0.0329
307 ANTIPHOSPHOLIPID SYNDROME 53 0.0329
308 GASTROINTESTINAL INJURY 87 0.0323
309 GENITAL HERPES 49 0.0320
310 APPENDICECTOMY 114 0.0319
311 WEIGHT LOSS POOR 163 0.0318
312 PRESYNCOPE 770 0.0316
313 COSTOCHONDRITIS 50 0.0307
314 GALACTORRHOEA 195 0.0303
315 DEPRESSION 6906 0.0303
316 MENOPAUSE 78 0.0303
317 WEIGHT INCREASED 6750 0.0301
318 FOOD CRAVING 157 0.0298
319 BREAST DISORDER 60 0.0294
320 ANXIETY DISORDER 96 0.0287
321 SEBORRHOEA 104 0.0283
322 VARICOSE VEIN 146 0.0282
323 PANIC ATTACK 1011 0.0277
324 EMOTIONAL DISORDER 847 0.0274
325 ALOPECIA AREATA 48 0.0273
326 GASTRIC BYPASS 59 0.0271
327 ABDOMINAL TENDERNESS 134 0.0270
328 CAESAREAN SECTION 313 0.0269
329 APPLICATION SITE RASH 366 0.0266
330 PROCEDURAL COMPLICATION 203 0.0264
331 DEPRESSED MOOD 1396 0.0264
332 FUNGAL INFECTION 870 0.0261
333 CERVIX CARCINOMA 100 0.0256
334 EMOTIONAL DISTRESS 3079 0.0254
335 AFFECT LABILITY 242 0.0251
336 ABDOMINAL ADHESIONS 79 0.0250
337 DISCOMFORT 1526 0.0250
338 PLEURITIC PAIN 69 0.0250
339 PREMATURE RUPTURE OF MEMBRANES 59 0.0245
340 PRODUCT CONTAMINATION 87 0.0244
341 HAIR GROWTH ABNORMAL 169 0.0244
342 IRRITABILITY 1462 0.0243
343 NEGATIVE THOUGHTS 71 0.0242
344 DEVICE DEFECTIVE 420 0.0242
345 VENOUS THROMBOSIS 95 0.0242
346 HYSTERECTOMY 207 0.0239
347 ANHEDONIA 618 0.0235
348 ANXIETY 6686 0.0235
349 CEREBRAL THROMBOSIS 66 0.0233
350 AUTOIMMUNE THYROIDITIS 88 0.0233
351 FEAR 621 0.0231
352 PHLEBITIS 114 0.0222
353 PRODUCT PHYSICAL ISSUE 448 0.0222
354 VISUAL FIELD DEFECT 159 0.0220
355 BACK PAIN 5066 0.0218
356 THYROID NEOPLASM 60 0.0217
357 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 133 0.0215
358 IRON DEFICIENCY ANAEMIA 196 0.0212
359 PRE-EXISTING CONDITION IMPROVED 132 0.0211
360 RHINITIS ALLERGIC 94 0.0211
361 MAJOR DEPRESSION 154 0.0211
362 ADVERSE EVENT 1936 0.0210
363 BREAST CANCER FEMALE 561 0.0210
364 CRYING 758 0.0208
365 MENINGIOMA 321 0.0205
366 FORMICATION 143 0.0205
367 INCORRECT DOSAGE ADMINISTERED 100 0.0204
368 HEPATIC CYST 68 0.0200
369 TEARFULNESS 86 0.0200
370 POST-TRAUMATIC STRESS DISORDER 134 0.0200
371 FIBRIN D DIMER INCREASED 70 0.0197
372 INTENTIONAL DEVICE MISUSE 86 0.0195
373 PANIC DISORDER 75 0.0193
374 ATELECTASIS 187 0.0193
375 DEPRESSIVE SYMPTOM 68 0.0193
376 HAEMORRHAGIC ANAEMIA 84 0.0191
377 MUSCLE SPASMS 3490 0.0190
378 DEVICE ADHESION ISSUE 291 0.0189
379 APPLICATION SITE IRRITATION 235 0.0189
380 SKIN ODOUR ABNORMAL 74 0.0188
381 FLANK PAIN 176 0.0188
382 CHOLECYSTECTOMY 210 0.0184
383 COAGULOPATHY 304 0.0182
384 DEVICE USE ERROR 632 0.0182
385 POOR QUALITY DEVICE USED 181 0.0180
386 TRICUSPID VALVE INCOMPETENCE 143 0.0180
387 HOT FLUSH 1356 0.0180
388 TENSION HEADACHE 77 0.0179
389 TRICHORRHEXIS 49 0.0176
390 PLEURISY 103 0.0173
391 PORTAL VEIN THROMBOSIS 56 0.0173
392 ALOPECIA 3354 0.0171
393 HAEMORRHAGE 1781 0.0170
394 EXPIRED DRUG ADMINISTERED 84 0.0170
395 IRON DEFICIENCY 76 0.0169
396 NIGHT SWEATS 537 0.0166
397 ERYTHEMA NODOSUM 57 0.0162
398 PRODUCT ADMINISTRATION INTERRUPTED 127 0.0162
399 HEADACHE 10111 0.0161
400 ABNORMAL WEIGHT GAIN 199 0.0161
401 PLANTAR FASCIITIS 54 0.0161
402 BIPOLAR DISORDER 175 0.0161
403 INTERNATIONAL NORMALISED RATIO DECREASED 65 0.0160
404 LIMB DISCOMFORT 496 0.0160
405 IMPAIRED WORK ABILITY 341 0.0159
406 PREMATURE LABOUR 89 0.0157
407 VERTIGO 951 0.0156
408 PRE-ECLAMPSIA 74 0.0156
409 PAIN 9479 0.0154
410 ANTINUCLEAR ANTIBODY POSITIVE 50 0.0154
411 HUNGER 214 0.0153
412 PSYCHOLOGICAL TRAUMA 131 0.0152
413 ANGER 513 0.0152
414 FOETAL DEATH 78 0.0150
415 CHOLECYSTITIS CHRONIC 100 0.0149
416 GESTATIONAL DIABETES 71 0.0149
417 VITAMIN B12 DEFICIENCY 60 0.0148
418 APPENDICITIS 138 0.0148
419 INTENTIONAL PRODUCT MISUSE 1286 0.0147
420 PANIC REACTION 106 0.0147
421 NAUSEA 11516 0.0145
422 APPLICATION SITE PRURITUS 330 0.0145
423 MUSCLE STRAIN 125 0.0144
424 GOITRE 59 0.0144
425 POLLAKIURIA 594 0.0142
426 DYSURIA 521 0.0141
427 OVERWEIGHT 76 0.0141
428 SELF-INJURIOUS IDEATION 59 0.0140
429 HYPOAESTHESIA 2089 0.0139
430 TINNITUS 638 0.0139
431 INCORRECT PRODUCT STORAGE 182 0.0138
432 MENTAL DISORDER 602 0.0138
433 SUICIDAL IDEATION 1251 0.0137
434 INCREASED APPETITE 261 0.0136
435 ABDOMINAL PAIN UPPER 2800 0.0136
436 PHARYNGITIS STREPTOCOCCAL 145 0.0134
437 MATERNAL EXPOSURE DURING PREGNANCY 1193 0.0134
438 SURGERY 781 0.0133
439 MICTURITION URGENCY 152 0.0133
440 THROMBOSIS 1067 0.0132
441 FEELING OF BODY TEMPERATURE CHANGE 76 0.0130
442 URINE ODOUR ABNORMAL 76 0.0129
443 NORMAL NEWBORN 70 0.0129
444 HYPERPHAGIA 51 0.0128
445 VOMITING 5958 0.0127
446 NERVOUSNESS 662 0.0127
447 PURULENT DISCHARGE 54 0.0126
448 PAROSMIA 95 0.0126
449 TENDERNESS 130 0.0125
450 LIGAMENT SPRAIN 123 0.0124
451 PRODUCT COLOUR ISSUE 63 0.0123
452 DIZZINESS 6021 0.0121
453 OBESITY 192 0.0120
454 APATHY 174 0.0119
455 HYPERVENTILATION 69 0.0119
456 EXPIRED PRODUCT ADMINISTERED 392 0.0118
457 APPLICATION SITE BURN 58 0.0118
458 PRODUCT SOLUBILITY ABNORMAL 58 0.0115
459 PYELONEPHRITIS 99 0.0114
460 ROSACEA 53 0.0114
461 FEELING OF DESPAIR 53 0.0114
462 NECK PAIN 634 0.0113
463 BLOOD URINE PRESENT 215 0.0113
464 PHARYNGITIS 140 0.0113
465 BLINDNESS TRANSIENT 83 0.0112
466 VITAMIN D DEFICIENCY 109 0.0112
467 STREPTOCOCCAL INFECTION 62 0.0111
468 PAIN IN EXTREMITY 3281 0.0111
469 PALPITATIONS 1304 0.0111
470 POOR QUALITY DRUG ADMINISTERED 72 0.0111
471 SYNCOPE 1104 0.0110
472 DECREASED INTEREST 65 0.0110
473 PHOTOPHOBIA 207 0.0110
474 DERMATITIS CONTACT 125 0.0109
475 PARAESTHESIA 1716 0.0109
476 MULTIPLE INJURIES 68 0.0108
477 HERPES SIMPLEX 70 0.0108
478 QUALITY OF LIFE DECREASED 144 0.0107
479 NEURALGIA 258 0.0106
480 NERVE INJURY 117 0.0105
481 GROIN PAIN 92 0.0105
482 APPLICATION SITE ERYTHEMA 272 0.0104
483 DIPLOPIA 269 0.0103
484 DRUG EXPOSURE DURING PREGNANCY 351 0.0103
485 ACTIVITIES OF DAILY LIVING IMPAIRED 204 0.0103
486 TENDONITIS 159 0.0103
487 MATERNAL DRUGS AFFECTING FOETUS 78 0.0102
488 GALLBLADDER DISORDER 181 0.0101
489 APPLICATION SITE REACTION 71 0.0101
490 EXPOSURE DURING PREGNANCY 618 0.0099
491 SENSATION OF FOREIGN BODY 83 0.0098
492 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 331 0.0098
493 PROCTALGIA 63 0.0098
494 EXTRASYSTOLES 68 0.0097
495 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 452 0.0097
496 URINARY TRACT INFECTION 1643 0.0096
497 APPLICATION SITE SWELLING 48 0.0096
498 MUSCULOSKELETAL CHEST PAIN 149 0.0096
499 HYPERLIPIDAEMIA 115 0.0096
500 FURUNCLE 76 0.0096
501 PIGMENTATION DISORDER 59 0.0095
502 DISTURBANCE IN ATTENTION 512 0.0095
503 BRAIN FOG 147 0.0094
504 FEELING ABNORMAL 2244 0.0094
505 AUTOIMMUNE DISORDER 91 0.0093
506 BACTERIAL INFECTION 173 0.0093
507 WEIGHT FLUCTUATION 97 0.0093
508 MUSCULOSKELETAL PAIN 484 0.0092
509 VISION BLURRED 1267 0.0092
510 SLEEP APNOEA SYNDROME 176 0.0092
511 RASH GENERALISED 237 0.0091
512 THYROID DISORDER 140 0.0091
513 FATIGUE 7045 0.0090
514 SEXUAL DYSFUNCTION 106 0.0090
515 MUSCLE TIGHTNESS 146 0.0090
516 CHOLELITHIASIS 293 0.0089
517 MITRAL VALVE INCOMPETENCE 101 0.0089
518 FRUSTRATION TOLERANCE DECREASED 72 0.0089
519 ADVERSE REACTION 118 0.0089
520 ABDOMINAL DISCOMFORT 1487 0.0089
521 IRRITABLE BOWEL SYNDROME 190 0.0089
522 PERSONALITY CHANGE 82 0.0088
523 SENSORY LOSS 71 0.0088
524 HEREDITARY ANGIOEDEMA 94 0.0088
525 HYPOTHYROIDISM 279 0.0087
526 FOOD ALLERGY 67 0.0087
527 APPLICATION SITE VESICLES 55 0.0085
528 CYSTITIS 269 0.0084
529 GRAND MAL CONVULSION 78 0.0084
530 APPETITE DISORDER 56 0.0084
531 SLEEP DISORDER 590 0.0084
532 PREMATURE DELIVERY 133 0.0083
533 AMNESIA 542 0.0083
534 INFECTION 1200 0.0083
535 NERVE COMPRESSION 76 0.0082
536 FOETAL GROWTH RESTRICTION 50 0.0082
537 LIMB INJURY 222 0.0082
538 CHEST PAIN 1508 0.0081
539 FEELING HOT 488 0.0080
540 SINUS TACHYCARDIA 113 0.0079
541 HEAD DISCOMFORT 140 0.0079
542 DRUG ADMINISTRATION ERROR 242 0.0079
543 SCREAMING 50 0.0078
544 LEUKOCYTOSIS 142 0.0078
545 MIDDLE INSOMNIA 146 0.0078
546 POOR QUALITY SLEEP 168 0.0078
547 PULMONARY MASS 116 0.0078
548 COLD SWEAT 137 0.0078
549 BLOOD IRON DECREASED 92 0.0077
550 PHOTOPSIA 49 0.0077
551 CARDIAC MURMUR 67 0.0077
552 INCREASED TENDENCY TO BRUISE 71 0.0077
553 DRUG PRESCRIBING ERROR 148 0.0077
554 HIDRADENITIS 70 0.0077
555 VISUAL IMPAIRMENT 949 0.0077
556 MEDICATION ERROR 425 0.0076
557 KIDNEY INFECTION 150 0.0076
558 URTICARIA 1270 0.0076
559 ROAD TRAFFIC ACCIDENT 317 0.0076
560 DEVICE RELATED INFECTION 116 0.0075
561 HYPERHIDROSIS 969 0.0075
562 OCULAR DISCOMFORT 84 0.0075
563 PSYCHIATRIC SYMPTOM 55 0.0074
564 ARTHROPOD BITE 55 0.0074
565 FACIAL PARALYSIS 63 0.0074
566 SEASONAL ALLERGY 104 0.0073
567 NEEDLE ISSUE 213 0.0073
568 PREMATURE BABY 219 0.0073
569 AGGRESSION 364 0.0073
570 CONCUSSION 56 0.0072
571 PRODUCT USE IN UNAPPROVED INDICATION 1783 0.0072
572 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1457 0.0072
573 SECRETION DISCHARGE 90 0.0072
574 GENERAL PHYSICAL HEALTH DETERIORATION 827 0.0071
575 INITIAL INSOMNIA 73 0.0071
576 HEPATIC STEATOSIS 132 0.0071
577 SKIN DISORDER 236 0.0071
578 DERMATITIS ALLERGIC 89 0.0071
579 ECZEMA 368 0.0070
580 APPLICATION SITE PAIN 154 0.0070
581 BLINDNESS 284 0.0070
582 DEVICE MALFUNCTION 489 0.0070
583 PRURITUS GENERALISED 150 0.0069
584 PULMONARY HYPERTENSION 144 0.0069
585 FIBROMYALGIA 168 0.0069
586 LYMPHADENOPATHY 243 0.0069
587 PRODUCT USE ISSUE 1290 0.0069
588 FLATULENCE 389 0.0069
589 EPILEPSY 209 0.0068
590 BREAST CANCER 637 0.0068
591 TACHYCARDIA 605 0.0068
592 MUSCLE TWITCHING 156 0.0068
593 SKIN HYPERPIGMENTATION 58 0.0067
594 EMBOLISM 56 0.0067
595 HAEMORRHOIDS 131 0.0067
596 VITREOUS FLOATERS 66 0.0067
597 CARPAL TUNNEL SYNDROME 94 0.0067
598 PULMONARY THROMBOSIS 73 0.0067
599 HYPERAESTHESIA 55 0.0067
600 MUSCULOSKELETAL DISCOMFORT 115 0.0067
601 LUNG INFILTRATION 59 0.0067
602 RENAL CYST 53 0.0067
603 BODY TEMPERATURE INCREASED 136 0.0067
604 GASTROINTESTINAL PAIN 73 0.0066
605 DEFORMITY 62 0.0066
606 INSOMNIA 1766 0.0066
607 GASTROOESOPHAGEAL REFLUX DISEASE 531 0.0066
608 LACERATION 62 0.0066
609 SCIATICA 105 0.0066
610 MASS 92 0.0066
611 SUPRAVENTRICULAR TACHYCARDIA 63 0.0066
612 TRANSIENT ISCHAEMIC ATTACK 221 0.0065
613 HEMIPLEGIA 54 0.0065
614 INTERNAL HAEMORRHAGE 74 0.0065
615 CONTUSION 623 0.0065
616 FLUID RETENTION 328 0.0064
617 DRUG INEFFECTIVE 8468 0.0064
618 PRODUCT PRESCRIBING ERROR 153 0.0064
619 COELIAC DISEASE 63 0.0064
620 CEREBRAL INFARCTION 156 0.0064
621 LIVE BIRTH 53 0.0063
622 ISCHAEMIC STROKE 113 0.0063
623 ATRIAL SEPTAL DEFECT 53 0.0063
624 JOINT INJURY 135 0.0063
625 OPTIC NEURITIS 57 0.0063
626 THERAPEUTIC RESPONSE UNEXPECTED 281 0.0063
627 CONVULSION 357 0.0062
628 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 107 0.0062
629 EAR DISCOMFORT 64 0.0062
630 NEPHROLITHIASIS 285 0.0062
631 LOSS OF CONSCIOUSNESS 796 0.0062
632 PARANOIA 107 0.0062
633 SUBARACHNOID HAEMORRHAGE 63 0.0062
634 ACCIDENTAL UNDERDOSE 89 0.0062
635 POST PROCEDURAL INFECTION 50 0.0061
636 UPPER RESPIRATORY TRACT INFECTION 284 0.0061
637 BLOOD DISORDER 49 0.0061
638 HEART RATE IRREGULAR 138 0.0061
639 PRODUCT PACKAGING ISSUE 58 0.0061
640 UTERINE CANCER 49 0.0061
641 SENSORY DISTURBANCE 96 0.0060
642 PERIPHERAL COLDNESS 82 0.0060
643 RASH MACULAR 208 0.0059
644 DERMATITIS 124 0.0059
645 VENTRICULAR EXTRASYSTOLES 61 0.0059
646 SKIN DISCOLOURATION 268 0.0058
647 FOREIGN BODY IN REPRODUCTIVE TRACT 52 0.0058
648 HYPERTHYROIDISM 84 0.0058
649 INJURY ASSOCIATED WITH DEVICE 118 0.0058
650 BURNING SENSATION 405 0.0058
651 IMPAIRED QUALITY OF LIFE 83 0.0058
652 SWELLING 540 0.0058
653 OVARIAN CANCER 53 0.0057
654 LOCAL SWELLING 100 0.0057
655 WEIGHT DECREASED 1588 0.0057
656 PRODUCT SUBSTITUTION ISSUE 327 0.0057
657 FEELING COLD 158 0.0057
658 BRONCHITIS 419 0.0057
659 EAR PAIN 110 0.0057
660 IMPAIRED DRIVING ABILITY 64 0.0056
661 PALLOR 153 0.0056
662 THROAT TIGHTNESS 152 0.0056
663 SINUSITIS 573 0.0056
664 RENAL PAIN 59 0.0056
665 GASTROENTERITIS 81 0.0055
666 URINARY INCONTINENCE 164 0.0055
667 SKIN INFECTION 62 0.0055
668 POST PROCEDURAL COMPLICATION 106 0.0055
669 ABSCESS 88 0.0055
670 KNEE OPERATION 54 0.0055
671 ARTHRALGIA 2275 0.0055
672 STAPHYLOCOCCAL INFECTION 180 0.0055
673 DIZZINESS POSTURAL 52 0.0054
674 HYPERSOMNIA 153 0.0053
675 TEMPERATURE INTOLERANCE 55 0.0053
676 PHARYNGEAL SWELLING 52 0.0053
677 THIRST 94 0.0053
678 GENERALISED TONIC-CLONIC SEIZURE 87 0.0053
679 HYPOAESTHESIA ORAL 79 0.0052
680 APHASIA 158 0.0052
681 RESTLESSNESS 191 0.0052
682 INTERVERTEBRAL DISC PROTRUSION 114 0.0052
683 HEMIPARESIS 88 0.0052
684 VISUAL ACUITY REDUCED 172 0.0052
685 HYPERTENSION 1095 0.0052
686 UNEVALUABLE EVENT 391 0.0052
687 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 931 0.0052
688 GASTROENTERITIS VIRAL 93 0.0051
689 EAR INFECTION 137 0.0051
690 IMPAIRED HEALING 169 0.0051
691 FEELING JITTERY 98 0.0051
692 CHROMATURIA 116 0.0051
693 CHOLECYSTITIS 61 0.0051
694 DYSPEPSIA 500 0.0051
695 CELLULITIS 255 0.0051
696 SWELLING FACE 325 0.0050
697 RASH PRURITIC 269 0.0050
698 BLINDNESS UNILATERAL 70 0.0050
699 VIRAL INFECTION 165 0.0050
700 HAIR TEXTURE ABNORMAL 66 0.0049
701 EATING DISORDER 105 0.0049
702 RESTLESS LEGS SYNDROME 89 0.0049
703 THINKING ABNORMAL 91 0.0049
704 RETCHING 104 0.0049
705 TRANSFUSION 51 0.0049
706 OROPHARYNGEAL PAIN 450 0.0049
707 BLADDER DISORDER 48 0.0048
708 GASTRITIS 127 0.0048
709 ECONOMIC PROBLEM 73 0.0048
710 PRODUCT ADMINISTRATION ERROR 97 0.0048
711 CHEST DISCOMFORT 491 0.0048
712 HEART RATE INCREASED 475 0.0048
713 SPINAL PAIN 56 0.0048
714 CHILLS 556 0.0047
715 DERMATITIS ATOPIC 250 0.0047
716 SCRATCH 50 0.0047
717 CONTRAINDICATED PRODUCT ADMINISTERED 143 0.0047
718 CARDIOMEGALY 58 0.0047
719 CIRCULATORY COLLAPSE 80 0.0047
720 PSYCHOTIC DISORDER 138 0.0047
721 ASTHENIA 1756 0.0047
722 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 256 0.0047
723 INFUSION SITE PAIN 60 0.0047
724 INFLAMMATION 240 0.0046
725 PERIPHERAL SWELLING 716 0.0046
726 MYALGIA 786 0.0046
727 MALAISE 2008 0.0046
728 ABASIA 113 0.0046
729 HYPERSENSITIVITY 848 0.0046
730 INTENTIONAL PRODUCT USE ISSUE 400 0.0046
731 ASTHMA 512 0.0045
732 LIP SWELLING 150 0.0045
733 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 216 0.0045
734 HAEMOPTYSIS 125 0.0045
735 SEIZURE 514 0.0044
736 RASH ERYTHEMATOUS 212 0.0044
737 PYREXIA 1530 0.0044
738 RASH PAPULAR 99 0.0044
739 PRURITUS 1690 0.0044
740 FACE OEDEMA 74 0.0044
741 SINUS DISORDER 86 0.0043
742 BEDRIDDEN 57 0.0043
743 HAEMATOMA 112 0.0043
744 CEREBROVASCULAR ACCIDENT 727 0.0043
745 OEDEMA PERIPHERAL 521 0.0043
746 ADVERSE DRUG REACTION 383 0.0043
747 ANAEMIA 801 0.0042
748 PARAESTHESIA ORAL 60 0.0042
749 INFLUENZA LIKE ILLNESS 342 0.0042
750 PERITONITIS 86 0.0041
751 CANDIDA INFECTION 70 0.0041
752 SYSTEMIC LUPUS ERYTHEMATOSUS 147 0.0041
753 DECREASED APPETITE 959 0.0041
754 TREMOR 684 0.0041
755 RASH 1795 0.0041
756 INCORRECT ROUTE OF DRUG ADMINISTRATION 145 0.0041
757 CONSTIPATION 883 0.0040
758 IMPAIRED GASTRIC EMPTYING 55 0.0040
759 EYE SWELLING 149 0.0040
760 INSURANCE ISSUE 61 0.0040
761 TOOTHACHE 72 0.0040
762 WHITE BLOOD CELL COUNT INCREASED 152 0.0040
763 BACK DISORDER 64 0.0039
764 PHOTOSENSITIVITY REACTION 65 0.0039
765 DRY EYE 196 0.0039
766 MOVEMENT DISORDER 126 0.0039
767 COGNITIVE DISORDER 181 0.0039
768 GASTROINTESTINAL DISORDER 347 0.0039
769 NASAL CONGESTION 227 0.0039
770 ABNORMAL BEHAVIOUR 153 0.0039
771 HIATUS HERNIA 50 0.0039
772 HYPOKALAEMIA 178 0.0039
773 LIVER FUNCTION TEST ABNORMAL 112 0.0038
774 SPEECH DISORDER 201 0.0038
775 PAIN IN JAW 108 0.0038
776 ANGINA PECTORIS 109 0.0038
777 ARRHYTHMIA 179 0.0038
778 SUICIDE ATTEMPT 229 0.0038
779 ERUCTATION 73 0.0038
780 FEEDING DISORDER 76 0.0037
781 LETHARGY 215 0.0037
782 PAIN OF SKIN 100 0.0037
783 DYSSTASIA 108 0.0037
784 PLEURAL EFFUSION 225 0.0037
785 MEMORY IMPAIRMENT 507 0.0037
786 ANKLE FRACTURE 57 0.0037
787 BLOOD PRESSURE INCREASED 560 0.0037
788 ANKYLOSING SPONDYLITIS 48 0.0036
789 PHARYNGEAL OEDEMA 56 0.0036
790 OFF LABEL USE 3185 0.0036
791 ORAL HERPES 71 0.0036
792 SKIN REACTION 51 0.0036
793 WOUND 101 0.0036
794 GINGIVAL BLEEDING 49 0.0036
795 SWOLLEN TONGUE 112 0.0036
796 MUSCULOSKELETAL STIFFNESS 312 0.0036
797 BLOOD POTASSIUM DECREASED 107 0.0036
798 MENTAL IMPAIRMENT 86 0.0035
799 TREATMENT NONCOMPLIANCE 194 0.0035
800 HAEMATURIA 121 0.0035
801 GASTRIC DISORDER 121 0.0035
802 FREQUENT BOWEL MOVEMENTS 95 0.0035
803 PRODUCT AVAILABILITY ISSUE 80 0.0035
804 SKIN IRRITATION 160 0.0035
805 OEDEMA 187 0.0034
806 DRUG INTERACTION 546 0.0034
807 NIGHTMARE 119 0.0034
808 HAEMATEMESIS 87 0.0034
809 IMMUNODEFICIENCY 51 0.0034
810 HEAD INJURY 108 0.0034
811 FOETAL EXPOSURE DURING PREGNANCY 277 0.0034
812 MANIA 56 0.0034
813 INTENTIONAL DOSE OMISSION 97 0.0034
814 EYE PAIN 190 0.0034
815 SOMNOLENCE 665 0.0033
816 DIARRHOEA 2131 0.0033
817 MUSCULAR WEAKNESS 371 0.0033
818 ILLNESS 334 0.0032
819 INTENTIONAL SELF-INJURY 65 0.0032
820 NERVOUS SYSTEM DISORDER 100 0.0032
821 PRODUCT DOSE OMISSION ISSUE 941 0.0032
822 DYSARTHRIA 120 0.0032
823 DISABILITY 63 0.0032
824 PRODUCT DOSE OMISSION IN ERROR 90 0.0032
825 HAEMATOCRIT DECREASED 63 0.0032
826 FOOT FRACTURE 60 0.0032
827 RASH MACULO-PAPULAR 70 0.0031
828 RECTAL HAEMORRHAGE 134 0.0031
829 MULTIPLE SCLEROSIS 149 0.0031
830 GAMMA-GLUTAMYLTRANSFERASE INCREASED 69 0.0031
831 CARDIOVASCULAR DISORDER 79 0.0031
832 ERYTHEMA 639 0.0031
833 BLOOD CHOLESTEROL INCREASED 144 0.0031
834 THROAT IRRITATION 138 0.0031
835 CONJUNCTIVITIS 57 0.0031
836 BLOOD BILIRUBIN INCREASED 83 0.0031
837 BLOOD PRESSURE DECREASED 204 0.0031
838 SKIN FISSURES 60 0.0031
839 DYSPNOEA 1732 0.0031
840 TOOTH DISORDER 68 0.0031
841 INTERNATIONAL NORMALISED RATIO INCREASED 87 0.0030
842 NASOPHARYNGITIS 560 0.0030
843 DYSPNOEA EXERTIONAL 114 0.0030
844 MOBILITY DECREASED 215 0.0030
845 ANAPHYLACTIC SHOCK 77 0.0030
846 OVERDOSE 644 0.0030
847 COLITIS ULCERATIVE 132 0.0030
848 ABNORMAL DREAMS 81 0.0029
849 INFLUENZA 324 0.0029
850 PRODUCT STORAGE ERROR 254 0.0029
851 HAEMATOCHEZIA 160 0.0029
852 JAUNDICE 78 0.0029
853 PRODUCT DOSE OMISSION 188 0.0029
854 RESPIRATORY TRACT INFECTION 75 0.0029
855 FLUSHING 290 0.0028
856 RESPIRATORY DISORDER 85 0.0028
857 BLISTER 159 0.0028
858 HEART RATE DECREASED 99 0.0028
859 DRUG DOSE OMISSION 464 0.0028
860 ANAPHYLACTIC REACTION 155 0.0028
861 EPISTAXIS 208 0.0028
862 ANGIOEDEMA 123 0.0028
863 SKIN LESION 76 0.0028
864 DISORIENTATION 108 0.0027
865 DYSGEUSIA 202 0.0027
866 JOINT SWELLING 328 0.0027
867 WRONG TECHNIQUE IN DRUG USAGE PROCESS 97 0.0027
868 C-REACTIVE PROTEIN INCREASED 97 0.0027
869 BALANCE DISORDER 230 0.0027
870 LIVER FUNCTION TEST INCREASED 57 0.0027
871 SNEEZING 59 0.0026
872 PHARMACEUTICAL PRODUCT COMPLAINT 68 0.0026
873 ACUTE MYOCARDIAL INFARCTION 77 0.0026
874 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 76 0.0026
875 EYE PRURITUS 87 0.0026
876 DISEASE RECURRENCE 123 0.0026
877 ASCITES 76 0.0026
878 MUSCULOSKELETAL DISORDER 49 0.0026
879 WITHDRAWAL SYNDROME 108 0.0026
880 SKIN BURNING SENSATION 184 0.0026
881 ALANINE AMINOTRANSFERASE INCREASED 157 0.0026
882 PANCREATITIS ACUTE 57 0.0025
883 DEAFNESS 65 0.0025
884 JOINT STIFFNESS 65 0.0025
885 DRY SKIN 324 0.0024
886 BLOOD PRESSURE FLUCTUATION 58 0.0024
887 DRY MOUTH 195 0.0024
888 HAEMOGLOBIN DECREASED 245 0.0024
889 GAIT DISTURBANCE 455 0.0024
890 SKIN EXFOLIATION 200 0.0024
891 AGITATION 174 0.0024
892 RHINORRHOEA 152 0.0023
893 DEHYDRATION 312 0.0023
894 URINARY RETENTION 78 0.0023
895 CONDITION AGGRAVATED 704 0.0023
896 EYE DISORDER 76 0.0023
897 PANCREATITIS 122 0.0023
898 COUGH 647 0.0023
899 TYPE 2 DIABETES MELLITUS 77 0.0023
900 LACRIMATION INCREASED 69 0.0023
901 ASPARTATE AMINOTRANSFERASE INCREASED 119 0.0022
902 BONE PAIN 131 0.0022
903 CEREBRAL HAEMORRHAGE 80 0.0022
904 DRUG-INDUCED LIVER INJURY 70 0.0022
905 ARTHROPATHY 123 0.0022
906 BLOOD ALKALINE PHOSPHATASE INCREASED 54 0.0022
907 PSORIATIC ARTHROPATHY 87 0.0021
908 THERAPEUTIC RESPONSE SHORTENED 71 0.0021
909 SHOCK 49 0.0021
910 GAIT INABILITY 71 0.0021
911 ARTHRITIS 166 0.0021
912 MENTAL STATUS CHANGES 58 0.0021
913 DYSPHAGIA 198 0.0021
914 AGEUSIA 52 0.0021
915 INJECTION SITE URTICARIA 51 0.0021
916 COVID-19 359 0.0020
917 HEPATIC ENZYME INCREASED 139 0.0020
918 DYSKINESIA 82 0.0020
919 PRODUCT COMPLAINT 51 0.0020
920 THERAPY CESSATION 103 0.0020
921 OSTEOARTHRITIS 85 0.0020
922 CONFUSIONAL STATE 320 0.0020
923 HYPOTENSION 397 0.0020
924 COLITIS 75 0.0020
925 PSORIASIS 258 0.0020
926 EYE IRRITATION 112 0.0019
927 INJECTION SITE PRURITUS 130 0.0019
928 SEPSIS 215 0.0019
929 INJECTION SITE REACTION 128 0.0019
930 INJECTION SITE RASH 57 0.0019
931 FALL 608 0.0018
932 LIVER DISORDER 81 0.0018
933 PNEUMONIA 582 0.0018
934 DIABETES MELLITUS 137 0.0018
935 SEPTIC SHOCK 77 0.0018
936 LUNG DISORDER 84 0.0017
937 OCULAR HYPERAEMIA 81 0.0017
938 RHEUMATOID ARTHRITIS 192 0.0017
939 INJECTION SITE SWELLING 129 0.0017
940 PRODUCTIVE COUGH 79 0.0017
941 THERAPEUTIC PRODUCT EFFECT DECREASED 74 0.0017
942 INJECTION SITE ERYTHEMA 203 0.0016
943 DRUG INTOLERANCE 157 0.0016
944 HYPERGLYCAEMIA 58 0.0016
945 THERAPEUTIC RESPONSE DECREASED 95 0.0016
946 DYSPHONIA 91 0.0016
947 MULTIPLE SCLEROSIS RELAPSE 106 0.0015
948 HERPES ZOSTER 87 0.0015
949 CARDIAC DISORDER 136 0.0015
950 INFUSION RELATED REACTION 94 0.0014
951 HYPOACUSIS 60 0.0014
952 RENAL DISORDER 64 0.0014
953 HALLUCINATION 103 0.0014
954 INJECTION SITE BRUISING 109 0.0014
955 DRUG EFFECT DECREASED 73 0.0014
956 HYPOGLYCAEMIA 65 0.0013
957 THERAPY NON-RESPONDER 60 0.0013
958 CARDIAC ARREST 110 0.0013
959 EXTRA DOSE ADMINISTERED 53 0.0013
960 BRADYCARDIA 69 0.0013
961 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 90 0.0013
962 DEPRESSED LEVEL OF CONSCIOUSNESS 50 0.0013
963 NEUROPATHY PERIPHERAL 120 0.0013
964 PULMONARY OEDEMA 56 0.0012
965 ILL-DEFINED DISORDER 74 0.0012
966 NEOPLASM MALIGNANT 80 0.0012
967 CARDIO-RESPIRATORY ARREST 49 0.0012
968 RESPIRATORY FAILURE 85 0.0012
969 WHEEZING 69 0.0012
970 INJECTION SITE PAIN 349 0.0011
971 ACCIDENTAL EXPOSURE TO PRODUCT 117 0.0011
972 THERAPY INTERRUPTED 81 0.0011
973 INCORRECT DOSE ADMINISTERED 247 0.0011
974 MYOCARDIAL INFARCTION 186 0.0011
975 HYPONATRAEMIA 60 0.0011
976 BLOOD GLUCOSE DECREASED 51 0.0011
977 OXYGEN SATURATION DECREASED 54 0.0010
978 TREATMENT FAILURE 79 0.0010
979 INTENTIONAL OVERDOSE 59 0.0009
980 THROMBOCYTOPENIA 102 0.0009
981 HOSPITALISATION 136 0.0009
982 BLOOD GLUCOSE INCREASED 162 0.0009
983 PLATELET COUNT DECREASED 88 0.0008
984 UNDERDOSE 57 0.0008
985 DRUG WITHDRAWAL SYNDROME 66 0.0008
986 INJECTION SITE HAEMORRHAGE 55 0.0007
987 ACUTE KIDNEY INJURY 92 0.0006
988 ATRIAL FIBRILLATION 58 0.0006
989 RENAL FAILURE 79 0.0006
990 WHITE BLOOD CELL COUNT DECREASED 64 0.0006
991 DRUG DEPENDENCE 54 0.0003
992 DEATH 136 0.0002